PALISADE BIO, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Wei Binxian | — | Option Exercise | 388 | — | — | 855 | Nov 21, 2024 |
| Williams Donald Allen | — | Option Exercise | 388 | — | — | 728 | Nov 21, 2024 |
| Wei Binxian | — | Option Exercise | 465 | — | — | 467 | Jun 11, 2024 |
| Williams Donald Allen | — | Option Exercise | 340 | — | — | 340 | Jun 11, 2024 |
| Jones Mitchell Lawrence | Chief Medical Officer | Tax Withholding | 461 | $4.76 | $2,194 | 3,852 | May 28, 2024 |
| Finley John David | CEO, CFO, Director | Option Exercise | 2,111 | — | — | 14,079 | May 28, 2024 |
| Williams Donald Allen | — | Purchase | 1,000 | $4.86 | $4,860 | 1,000 | May 28, 2024 |
| Finley John David | CEO, CFO, Director | Purchase | 1,000 | $4.81 | $4,810 | 8,437 | May 24, 2024 |
| Finley John David | CEO, CFO, Director | Award / Grant | 666 | $4.97 | $3,310 | 7,437 | May 20, 2024 |
| Jones Mitchell Lawrence | CEO, CFO, Director | Tax Withholding | 90 | $8.46 | $761 | 724 | May 6, 2024 |
| Finley John David | CEO, CFO, Director | Tax Withholding | 67 | $8.46 | $567 | 6,621 | May 6, 2024 |
| Finley John David | CEO, CFO, Director | Option Exercise | 5,558 | — | — | 96,849 | Mar 11, 2024 |
| Neal James R | — | Option Exercise | 5,100 | — | — | 5,100 | Feb 9, 2024 |
| Csimma Cristina | — | Option Exercise | 6,980 | — | — | 7,042 | Feb 8, 2024 |
| Diaz Stephanie | — | Option Exercise | 5,820 | — | — | 12,800 | Feb 8, 2024 |
| Trenschel Robert J. | — | Option Exercise | 5,820 | — | — | 10,920 | Feb 8, 2024 |
| Jones Mitchell Lawrence | Chief Medical Officer | Option Exercise | 2,333 | — | — | 9,815 | Feb 6, 2024 |
| Finley John David | CEO, CFO, Director | Option Exercise | 3,475 | — | — | 88,124 | Feb 6, 2024 |
| Finley John David | CEO, CFO, Director | Purchase | 10,000 | $0.47 | $4,700 | 84,649 | Feb 6, 2024 |
| Finley John David | CEO, CFO, Director | Purchase | 10,000 | $0.56 | $5,600 | 74,649 | Jan 31, 2024 |
| Williams Donald Allen | — | Purchase | 10,000 | $0.61 | $6,100 | 30,000 | Jan 31, 2024 |
| Finley John David | CEO, CFO, Director | Option Exercise | 1,309 | — | — | 64,649 | Jan 3, 2024 |
| Finley John David | CEO, CFO, Director | Option Exercise | 5,559 | — | — | 63,340 | Dec 11, 2023 |
| Finley John David | CEO, CFO, Director | Award / Grant | 10,000 | $0.51 | $5,100 | 57,781 | Nov 20, 2023 |
| Jones Mitchell Lawrence | Chief Medical Officer | Option Exercise | 4,556 | — | — | 4,556 | Nov 7, 2023 |
| Finley John David | CEO, CFO, Director | Option Exercise | 3,475 | — | — | 47,781 | Nov 6, 2023 |
| Finley John David | CEO, CFO, Director | Tax Withholding | 397 | $0.55 | $218 | 44,306 | Oct 3, 2023 |
| Williams Donald Allen | — | Purchase | 20,000 | $0.54 | $10,800 | 20,000 | Sep 27, 2023 |
| Finley John David | CEO, CFO, Director | Purchase | 15,000 | $0.54 | $8,100 | 43,394 | Sep 27, 2023 |
| Trenschel Robert J. | — | Sale | 300 | $0.64 | $192 | — | Sep 14, 2023 |
| Finley John David | CEO, CFO, Director | Purchase | 15,000 | $0.66 | $9,900 | 28,394 | Sep 13, 2023 |
| Finley John David | CEO, CFO, Director | Tax Withholding | 1,792 | $0.66 | $1,183 | 13,394 | Sep 11, 2023 |
| Finley John David | CEO, CFO, Director | Tax Withholding | 1,040 | $0.70 | $728 | 9,628 | Aug 6, 2023 |
| Finley John David | CEO, CFO, Director | Option Exercise | 1,309 | — | — | 7,582 | Jul 6, 2023 |
| Finley John David | CEO, CFO, Director | Option Exercise | 3,475 | — | — | 7,323 | Jun 13, 2023 |
| McRae Robert Curtis | Chief Operating Officer | Option Exercise | 655 | — | — | 895 | Apr 3, 2023 |
| Finley John David | CEO, CFO, Director | Tax Withholding | 435 | $2.01 | $874 | 3,848 | Apr 3, 2023 |
| Finley John David | Chief Financial Officer | Purchase | 19,481 | $0.14 | $2,727 | 148,727 | Sep 1, 2022 |
| Finley John David | Chief Financial Officer | Purchase | 7,350 | $0.16 | $1,176 | 129,246 | Aug 23, 2022 |
| Hallam Thomas | Chief Executive Officer | Purchase | 40,000 | $0.25 | $10,000 | 57,592 | Aug 16, 2022 |
| Finley John David | Chief Financial Officer | Purchase | 100,000 | $0.25 | $25,000 | 121,896 | Aug 16, 2022 |
| Finley John David | Chief Financial Officer | Other | 12,545 | — | — | 38,867 | Apr 29, 2022 |
| Dawson Michael John | Chief Medical Officer | Purchase | 15,000 | $1.14 | $17,100 | 15,000 | Mar 29, 2022 |
| Hallam Thomas | Chief Executive Officer | Purchase | 10,000 | $1.18 | $11,800 | 17,592 | Mar 28, 2022 |
| Finley John David | Chief Financial Officer | Purchase | 7,500 | $1.09 | $8,175 | 21,896 | Mar 24, 2022 |
| Finley John David | Chief Financial Officer | Purchase | 2,000 | $2.44 | $4,880 | 14,396 | Sep 21, 2021 |
| Hallam Thomas | Chief Executive Officer | Purchase | 6,000 | $2.49 | $14,940 | 7,592 | Sep 21, 2021 |
| Trenschel Robert J. | — | Purchase | 5,000 | $2.75 | $13,750 | 9,457 | Sep 10, 2021 |
| Finley John David | Chief Financial Officer | Purchase | 1,600 | $2.63 | $4,208 | 3,996 | Aug 27, 2021 |
| Trenschel Robert J. | — | Award / Grant | 304,479 | — | — | 304,479 | Apr 27, 2021 |